Application 020593

Type
NDA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEPACONVALPROATE SODIUMINJECTABLE;INJECTIONEQ 100MG BASE/MLYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0074-1564DepaconValproate SodiumAbbVie Inc.NDACurrent
0074-1564DepaconValproate SodiumAbbVie Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
63196SUPPL2020-05-20
63161SUPPL2020-05-20
61065SUPPL2019-11-26
61060SUPPL2019-11-26
57784SUPPL2019-02-22
57764SUPPL2019-02-22
54090SUPPL2018-05-10
54069SUPPL2018-05-10
50002SUPPL2017-10-10
49981SUPPL2017-10-06
47505SUPPL2017-03-08
47482SUPPL2017-03-07
45843SUPPL2016-11-08
45814SUPPL2016-11-04
34923SUPPL2016-02-23
25275SUPPL2016-02-23
12808SUPPL2015-10-06
2827SUPPL2015-09-25
34922SUPPL2015-03-17
2826SUPPL2015-03-17
25272SUPPL2015-01-08
12806SUPPL2015-01-08
34920SUPPL2014-12-03
25271SUPPL2014-11-24
34921SUPPL2014-08-22
25274SUPPL2014-08-21
25270SUPPL2014-06-23
12803SUPPL2014-06-23
25273SUPPL2014-06-11
12807SUPPL2014-06-10
34918SUPPL2013-09-17
2825SUPPL2013-09-17
34919SUPPL2013-07-02
34917SUPPL2013-03-04
2824SUPPL2013-03-01
25269SUPPL2011-10-13
2823SUPPL2011-10-13
2822SUPPL2011-10-13
12804SUPPL2011-10-12
34916SUPPL2011-10-07
12805SUPPL2011-10-07
41459SUPPL2008-02-19
44060ORIG2008-02-01
2821SUPPL2006-10-23
12802SUPPL2006-10-18
25268SUPPL2006-01-20
34915SUPPL2006-01-13
2820SUPPL2004-06-02
12801SUPPL2002-01-24
2819SUPPL2002-01-24